Mr Paice is taking part in the Tour De 4 cycling challenge on Sunday, September 7 to raise funds for Prostate Cancer UK.

Just 68 per cent of Canadians received a hip replacement within the 26-week benchmark last year, compared to 75 per cent in ...

A new study from the University of Michigan sheds light on the genetic roots of a deadly form of ovarian cancer and points ...

The drug, Ibtrozi, will now vie for market share in an indication where multiple large pharmaceutical companies have already struggled to grow sales.

Dr. Joshua K. Sabari sat down with Dr. Daniel V. Araujo to discuss topline takeaways from the 2025 ASCO Meeting across the ...

Researchers found that when the cancer cells were zapped with infrared light, it triggered violent shaking that tore through ...

Researchers are studying axolotls -- "small, smiling salamanders" -- in the hopes of learning how humans might one day regrow ...

In a new study, biking regularly for transportation appeared to lower risk of dementia by 19% and Alzheimer's disease by 22%.

The multimodal ArteraAI Prostate Test combines digital images of patients' biopsies and clinical data to predict prognoses and treatment outcomes.

Instead of homing in on PSMA—currently the most validated target in prostate cancer—BMS and Philochem will instead ...

The FDA has approved Nubeqa (darolutamide), an androgen receptor inhibitor, for the treatment of mCSPC in adults.